8-K - Lexaria Bioscience Corp. | StockGist

Current Report Details

Event Type

Material Agreement

Securities Issuance

Other Event

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On December 14, 2025, Lexaria Bioscience Corp., a Nevada corporation (the “Company”), entered into a securities purc

Material Agreement

$1.32$1.19

Source Document

3.02

Unregistered Sale of Equity Securities. The applicable information set forth in Item 1.01 of this Form 8-K with respect to the issuance of Private Placement War

Securities Issuance

8.01

of this Form 8-K. 3 Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 4.1 Form of Private Placement Warrant 4.2 Form of Placeme

Other Event

Exhibits (7)

10.1

SECURITIES PURCHASE AGREEMENT

4.1

COMMON STOCK PURCHASE WARRANT

4.2

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT

5.1

OPINION

8-K

FORM 8-K

99.1

PRESS RELEASE

99.2

PRESS RELEASE